Publication not explained
This publication has not yet been explained in plain language by the author(s). However, you can still read the publication.
If you are one of the authors, claim this publication so you can create a plain language summary to help more people find, understand and use it.
Featured Image
Read the Original
This page is a summary of: Response to: S. Sega-Jazbec et al.: “Management of infusion related reactions associated with alemtuzumab in patients with multiple sclerosis” Multiple Sclerosis and Related Disorders 2017, Multiple Sclerosis and Related Disorders, October 2017, Elsevier,
DOI: 10.1016/j.msard.2017.08.001.
You can read the full text:
Contributors
The following have contributed to this page
